Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy

A. Baba, T. Yoshikawa, M. Chino, A. Murayama, K. Mitani, S. Nakagawa, I. Fujii, M. Shimada, M. Akaishi, S. Iwanaga, Y. Asakura, Keiichi Fukuda, H. Mitamura, S. Ogawa

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Few previous reports have comprehensively screened all the anti-myocardial autoantibodies (AMCA) in relation to other clinical profiles in patients with idiopathic dilated cardiomyopathy (IDC), so the present study used both immunohistochemistry (FITC) and immunoblotting (IB) for screening patients with IDC in order to characterize the clinical significance of AMCA. Sera were collected from 100 patients with IDC and age-matched 100 healthy control subjects (CTL). For FITC, an unfixed frozen section of human myocardium was used for the standard indirect immunofluorescence; for IB, total cardiac homogenates of the same myocardium were blotted to serum at 2 sets of dilution (1:200 and 1:10,000). The positive rates of AMCA detection for each method were as follows (IDC vs CTL); 39% vs 6% for FITC, 38% vs 4% for IB (1:200), and 10% vs 0% for IB (1:10,000). Fifty-nine patients with IDC and 8 CTL were positive for AMCA by either method, and 18 patients with IDC and 2 CTL were positive for AMCA by both methods. IB-positivity at 1:200 was an independent predictor by multiple logistic regression analysis of non-sustained ventricular tachycardias as well as left ventricular end-diastolic diameter and plasma norepinephrine concentration.

Original languageEnglish
Pages (from-to)867-873
Number of pages7
JournalJapanese Circulation Journal
Volume65
Issue number10
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Dilated Cardiomyopathy
Autoantibodies
Immunoblotting
Fluorescein-5-isothiocyanate
Myocardium
Frozen Sections
Ventricular Tachycardia
Indirect Fluorescent Antibody Technique
Serum
Norepinephrine
Healthy Volunteers
Logistic Models
Immunohistochemistry
Regression Analysis

Keywords

  • Autoantibodies
  • Dilated cardiomyopathy
  • Immunoblotting
  • Immunohistochemistry

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Baba, A., Yoshikawa, T., Chino, M., Murayama, A., Mitani, K., Nakagawa, S., ... Ogawa, S. (2001). Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy. Japanese Circulation Journal, 65(10), 867-873. https://doi.org/10.1253/jcj.65.867

Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy. / Baba, A.; Yoshikawa, T.; Chino, M.; Murayama, A.; Mitani, K.; Nakagawa, S.; Fujii, I.; Shimada, M.; Akaishi, M.; Iwanaga, S.; Asakura, Y.; Fukuda, Keiichi; Mitamura, H.; Ogawa, S.

In: Japanese Circulation Journal, Vol. 65, No. 10, 2001, p. 867-873.

Research output: Contribution to journalArticle

Baba, A, Yoshikawa, T, Chino, M, Murayama, A, Mitani, K, Nakagawa, S, Fujii, I, Shimada, M, Akaishi, M, Iwanaga, S, Asakura, Y, Fukuda, K, Mitamura, H & Ogawa, S 2001, 'Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy', Japanese Circulation Journal, vol. 65, no. 10, pp. 867-873. https://doi.org/10.1253/jcj.65.867
Baba, A. ; Yoshikawa, T. ; Chino, M. ; Murayama, A. ; Mitani, K. ; Nakagawa, S. ; Fujii, I. ; Shimada, M. ; Akaishi, M. ; Iwanaga, S. ; Asakura, Y. ; Fukuda, Keiichi ; Mitamura, H. ; Ogawa, S. / Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy. In: Japanese Circulation Journal. 2001 ; Vol. 65, No. 10. pp. 867-873.
@article{05377a4aacdd48039e8dceb758165a4f,
title = "Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy",
abstract = "Few previous reports have comprehensively screened all the anti-myocardial autoantibodies (AMCA) in relation to other clinical profiles in patients with idiopathic dilated cardiomyopathy (IDC), so the present study used both immunohistochemistry (FITC) and immunoblotting (IB) for screening patients with IDC in order to characterize the clinical significance of AMCA. Sera were collected from 100 patients with IDC and age-matched 100 healthy control subjects (CTL). For FITC, an unfixed frozen section of human myocardium was used for the standard indirect immunofluorescence; for IB, total cardiac homogenates of the same myocardium were blotted to serum at 2 sets of dilution (1:200 and 1:10,000). The positive rates of AMCA detection for each method were as follows (IDC vs CTL); 39{\%} vs 6{\%} for FITC, 38{\%} vs 4{\%} for IB (1:200), and 10{\%} vs 0{\%} for IB (1:10,000). Fifty-nine patients with IDC and 8 CTL were positive for AMCA by either method, and 18 patients with IDC and 2 CTL were positive for AMCA by both methods. IB-positivity at 1:200 was an independent predictor by multiple logistic regression analysis of non-sustained ventricular tachycardias as well as left ventricular end-diastolic diameter and plasma norepinephrine concentration.",
keywords = "Autoantibodies, Dilated cardiomyopathy, Immunoblotting, Immunohistochemistry",
author = "A. Baba and T. Yoshikawa and M. Chino and A. Murayama and K. Mitani and S. Nakagawa and I. Fujii and M. Shimada and M. Akaishi and S. Iwanaga and Y. Asakura and Keiichi Fukuda and H. Mitamura and S. Ogawa",
year = "2001",
doi = "10.1253/jcj.65.867",
language = "English",
volume = "65",
pages = "867--873",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "10",

}

TY - JOUR

T1 - Characterization of anti-myocardial autoantibodies in Japanese patients with dilated cardiomyopathy

AU - Baba, A.

AU - Yoshikawa, T.

AU - Chino, M.

AU - Murayama, A.

AU - Mitani, K.

AU - Nakagawa, S.

AU - Fujii, I.

AU - Shimada, M.

AU - Akaishi, M.

AU - Iwanaga, S.

AU - Asakura, Y.

AU - Fukuda, Keiichi

AU - Mitamura, H.

AU - Ogawa, S.

PY - 2001

Y1 - 2001

N2 - Few previous reports have comprehensively screened all the anti-myocardial autoantibodies (AMCA) in relation to other clinical profiles in patients with idiopathic dilated cardiomyopathy (IDC), so the present study used both immunohistochemistry (FITC) and immunoblotting (IB) for screening patients with IDC in order to characterize the clinical significance of AMCA. Sera were collected from 100 patients with IDC and age-matched 100 healthy control subjects (CTL). For FITC, an unfixed frozen section of human myocardium was used for the standard indirect immunofluorescence; for IB, total cardiac homogenates of the same myocardium were blotted to serum at 2 sets of dilution (1:200 and 1:10,000). The positive rates of AMCA detection for each method were as follows (IDC vs CTL); 39% vs 6% for FITC, 38% vs 4% for IB (1:200), and 10% vs 0% for IB (1:10,000). Fifty-nine patients with IDC and 8 CTL were positive for AMCA by either method, and 18 patients with IDC and 2 CTL were positive for AMCA by both methods. IB-positivity at 1:200 was an independent predictor by multiple logistic regression analysis of non-sustained ventricular tachycardias as well as left ventricular end-diastolic diameter and plasma norepinephrine concentration.

AB - Few previous reports have comprehensively screened all the anti-myocardial autoantibodies (AMCA) in relation to other clinical profiles in patients with idiopathic dilated cardiomyopathy (IDC), so the present study used both immunohistochemistry (FITC) and immunoblotting (IB) for screening patients with IDC in order to characterize the clinical significance of AMCA. Sera were collected from 100 patients with IDC and age-matched 100 healthy control subjects (CTL). For FITC, an unfixed frozen section of human myocardium was used for the standard indirect immunofluorescence; for IB, total cardiac homogenates of the same myocardium were blotted to serum at 2 sets of dilution (1:200 and 1:10,000). The positive rates of AMCA detection for each method were as follows (IDC vs CTL); 39% vs 6% for FITC, 38% vs 4% for IB (1:200), and 10% vs 0% for IB (1:10,000). Fifty-nine patients with IDC and 8 CTL were positive for AMCA by either method, and 18 patients with IDC and 2 CTL were positive for AMCA by both methods. IB-positivity at 1:200 was an independent predictor by multiple logistic regression analysis of non-sustained ventricular tachycardias as well as left ventricular end-diastolic diameter and plasma norepinephrine concentration.

KW - Autoantibodies

KW - Dilated cardiomyopathy

KW - Immunoblotting

KW - Immunohistochemistry

UR - http://www.scopus.com/inward/record.url?scp=0034756393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034756393&partnerID=8YFLogxK

U2 - 10.1253/jcj.65.867

DO - 10.1253/jcj.65.867

M3 - Article

C2 - 11665790

AN - SCOPUS:0034756393

VL - 65

SP - 867

EP - 873

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 10

ER -